.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Federal Trade Commission
Covington
Merck
Argus Health
Queensland Health
US Army
McKinsey
Teva
Fish and Richardson

Generated: June 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074052

« Back to Dashboard
NDA 074052 describes ATENOLOL, which is a drug marketed by Zydus Pharms Usa, Pliva, Alvogen Malta, Able, Sun Pharm Inds Inc, Aurobindo Pharma, Teva, Apothecon, Teva Pharms, Sandoz, Mylan, Nostrum Labs, Dava Pharms Inc, Unique Pharm Labs, Watson Labs, Watson Labs Teva, Northstar Hlthcare, Sun Pharm Inds, SCS, Ipca Labs Ltd, and Mutual Pharm, and is included in forty-one NDAs. It is available from fifty-seven suppliers. Additional details are available on the ATENOLOL profile page.

The generic ingredient in ATENOLOL is atenolol; chlorthalidone. There are thirty-three drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.

Summary for NDA: 074052

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 074052

Mechanism of ActionAdrenergic beta-Antagonists

Suppliers and Packaging for NDA: 074052

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATENOLOL
atenolol
TABLET;ORAL 074052 ANDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-3544 0615-3544-05 15 TABLET in 1 BLISTER PACK (0615-3544-05)
ATENOLOL
atenolol
TABLET;ORAL 074052 ANDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-3544 0615-3544-30 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-3544-30) > 5 TABLET in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:May 1, 1992TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Cipla
Mallinckrodt
Dow
Fish and Richardson
Deloitte
Argus Health
Colorcon
Novartis
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot